Outcomes for RT Duration as a Continuous Variable
ONCOLOGY
After controlling for an NRG Oncology trial, a 1-week increase in RT duration was associated with a 17% increased risk of having a DFS failure (HR, 1.17; 95% CI, 1.04-1.32; 